Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Atenolol Prices, Demand and Supply Overview
Atenolol prices in Germany, the highest-cost reporting region, rose 8.1% in H1 2026, climbing from USD 31.0/KG in Q1 to USD 33.5/KG by Q2 as spring antihypertensive and angina pectoris formulation procurement and firmer cardioselective beta-blocker synthesis feedstock costs drove consistent buying following the brief Q1 2026 pricing moderation. Globally, the average rose from USD 22.00/KG in Q1 to USD 23.76/KG in Q2, an 8.0% gain. For H2 2026, a global average of USD 23.90-26.60/KG is expected, with continued firming on Middle East supply disruptions and growing antihypertensive and cardiac arrhythmia treatment sector demand globally.
Atenolol is a cardioselective beta-1 adrenergic receptor antagonist without intrinsic sympathomimetic activity, produced by multi-step synthesis from para-hydroxyphenylacetamide precursors through N-alkylation with tert-butylamine and epichlorohydrin and ether formation to yield the 4-[2-hydroxy-3-(tert-butylamino)propoxy]phenylacetamide free base. The compound’s hydrophilic physicochemical properties result in negligible central nervous system penetration, reduced hepatic first-pass metabolism, predominantly renal excretion, and a plasma half-life of six to nine hours supporting twice-daily or once-daily dosing regimens, advantages over lipophilic beta-blockers in patients with hepatic impairment. The largest pull comes from hypertension management as first-line or combination antihypertensive therapy across adult hypertensive populations globally, where competitive generic pricing and established tolerability support high prescribing volumes across both high-income and lower-middle-income health systems. Angina pectoris management, cardiac arrhythmia suppression, and acute myocardial infarction early treatment add further significant demand. Anxiety disorder off-label use and hyperthyroidism adjunctive symptom management add consistent volumes globally. Beta-blocker synthesis feedstock costs, antihypertensive and cardiac arrhythmia prescription volumes, and regional API production capacity in China and India all feed into the price.
Atenolol Price Forecast for 2026
The balance of supply and demand for atenolol through H2 2026 leans moderately firm. Beta-blocker synthesis feedstock costs firmed from Middle East supply disruptions. Antihypertensive prescribing volumes and cardiac management procurement are growing with expanding healthcare access and hypertension awareness globally.
The main upside risk is synthesis feedstock cost increases alongside accelerating antihypertensive access programme procurement. The main downside risk is Chinese and Indian API surplus maintaining competitive price pressure below the forecast range.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 23.90 - 26.60 | Synthesis cost firming and antihypertensive/cardiac demand support |
| United States | 25.70 - 28.40 | Steady antihypertensive and cardiac demand holds firm |
| China | 17.90 - 20.60 | Large API capacity keeps it the most affordable |
| Germany | 33.90 - 36.60 | High synthesis and energy costs keep it the most expensive |
| India | 24.70 - 27.40 | Growing antihypertensive and export demand holds a firm middle |
For the Quarter Ending June 2026
Atenolol Prices Q2 2026:
- United States: USD 27.3/KG
- China: USD 19.0/KG
- Germany: USD 33.5/KG
- India: USD 26.1/KG
Atenolol Prices in the United States
US Atenolol prices averaged USD 27.3/KG in Q2 2026, up 7.9% from USD 25.3/KG in Q1 2026. Firmer synthesis feedstock costs and spring antihypertensive and cardiac arrhythmia procurement drove consistent buying following the Q1 moderation.
Why did the price of Atenolol change in Q2 2026 in the United States?
Firmer beta-blocker synthesis feedstock costs raised the API production floor. Antihypertensive, angina, and cardiac arrhythmia formulation procurement lifted buying. Acute myocardial infarction early treatment and anxiety management demand provided additional support near USD 27.3/KG.
Atenolol Prices in China
Chinese Atenolol prices averaged USD 19.0/KG in Q2 2026, up 8.0% from USD 17.6/KG in Q1 2026, the lowest among the tracked markets. Spring antihypertensive and cardiac export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite domestic API capacity.
Why did the price of Atenolol change in Q2 2026 in China?
Spring antihypertensive and cardiac arrhythmia export and domestic procurement lifted buying. Firmer domestic synthesis feedstock costs raised the production floor. Domestic API capacity kept China the most affordable source.
Atenolol Prices in Germany
German Atenolol prices averaged USD 33.5/KG in Q2 2026, up 8.1% from USD 31.0/KG in Q1 2026, the highest among the tracked markets. Higher synthesis feedstock and energy costs elevated European API production economics. Consistent antihypertensive, angina, and cardiac arrhythmia demand maintained steady buying.
Why did the price of Atenolol change in Q2 2026 in Germany?
Higher beta-blocker synthesis feedstock and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to synthesis substrate chains. Consistent antihypertensive and cardiac formulation procurement maintained buying near USD 33.5/KG.
Atenolol Prices in India
Indian Atenolol prices averaged USD 26.1/KG in Q2 2026, up 7.9% from USD 24.2/KG in Q1 2026. Growing antihypertensive and cardiac export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Atenolol change in Q2 2026 in India?
Growing antihypertensive and cardiac arrhythmia export and domestic procurement lifted buying. Firmer synthesis import costs raised the production floor. Angina and acute MI treatment export demand provided additional support near USD 26.1/KG.
For the Quarter Ending March 2026
Atenolol Prices Q1 2026:
- United States: USD 25.3/KG
- China: USD 17.6/KG
- Germany: USD 31.0/KG
- India: USD 24.2/KG
Atenolol Prices in the United States
US Atenolol prices averaged USD 25.3/KG in Q1 2026, easing about 1.0% from Q4 2025. Post-quarter antihypertensive and cardiac procurement moderation and soft synthesis costs eased the market before the Q2 spring procurement surge.
Why did the price of Atenolol change in Q1 2026 in the United States?
Post-quarter antihypertensive and cardiac arrhythmia procurement moderation reduced buying urgency. Soft synthesis feedstock costs eased the production floor. The market eased to USD 25.3/KG before the Q2 spring procurement surge.
Atenolol Prices in China
Chinese prices averaged USD 17.6/KG in Q1 2026, easing about 0.9% from Q4 2025. Post-Lunar New Year procurement moderation and soft synthesis costs held the market near USD 17.6/KG.
Why did the price of Atenolol change in Q1 2026 in China?
Post-Lunar New Year antihypertensive export and domestic procurement moderation reduced urgency. Soft domestic synthesis costs eased the production floor. The market eased to USD 17.6/KG before Q2 surge.
Atenolol Prices in Germany
German prices averaged USD 31.0/KG in Q1 2026, easing about 1.0% from Q4 2025. Post-quarter antihypertensive and cardiac procurement moderation and soft synthesis and energy costs eased the European market near USD 31.0/KG.
Why did the price of Atenolol change in Q1 2026 in Germany?
Post-quarter antihypertensive and cardiac arrhythmia procurement moderation reduced urgency. Soft synthesis feedstock and energy costs eased the production floor. The market eased to USD 31.0/KG before the Q2 spring procurement surge.
Atenolol Prices in India
Indian prices averaged USD 24.2/KG in Q1 2026, easing about 0.8% from Q4 2025. Post-holiday procurement moderation and soft synthesis import costs held the market near USD 24.2/KG.
Why did the price of Atenolol change in Q1 2026 in India?
Post-holiday antihypertensive and cardiac procurement moderation reduced urgency. Soft synthesis import costs eased the production floor. The market eased to USD 24.2/KG before the Q2 spring surge.
Quarterly Atenolol Price Trends
Global Atenolol prices followed an alternating pattern, dipping in Q3 2025 and Q1 2026 on seasonal procurement moderation before recovering in Q4 2025 and surging in Q2 2026. The average eased from USD 22.0/KG in Q2 2025 to USD 21.78/KG in Q3, recovered to USD 22.22/KG in Q4, eased to USD 22.00/KG in Q1 2026, then surged to USD 23.76/KG in Q2 2026, a net gain of about 8.0% over the window. Synthesis feedstock cost cycles and antihypertensive and cardiac procurement seasonality drove the alternating pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 23.76 | +8.0% | ↑ Rising |
| Q1 2026 | 22.00 | -1.0% | ↓ Falling |
| Q4 2025 | 22.22 | +2.0% | ↑ Rising |
| Q3 2025 | 21.78 | -1.0% | ↓ Falling |
| Q2 2025 | 22.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
What was Atenolol Price in 2025?
Atenolol prices firmed modestly through 2025 on consistent antihypertensive and cardiac demand. The global average opened near USD 21.8/KG in Q1 2025 and closed at USD 22.22/KG in Q4, a full-year gain of about 1.9%. Synthesis feedstock cost dynamics and antihypertensive and cardiac procurement seasonality drove the quarterly oscillation throughout.
Atenolol Prices in the United States in 2025
US prices firmed from about USD 25.2/KG in Q1 2025 to USD 25.6/KG by Q4, a gain of 1.6%. Consistent antihypertensive, angina, and cardiac demand maintained the modest upward trend.
Atenolol Prices in China in 2025
Chinese prices firmed from roughly USD 17.5/KG in Q1 2025 to USD 17.8/KG by Q4, a gain of 1.7%. Growing antihypertensive export and domestic demand drove modest firming through the year.
Atenolol Prices in Germany in 2025
German prices firmed from about USD 30.8/KG in Q1 2025 to USD 31.3/KG by Q4, a gain of 1.6%. Consistent antihypertensive, angina, and cardiac demand and firm synthesis costs supported the market.
Atenolol Prices in India in 2025
Indian prices firmed from roughly USD 24.0/KG in Q1 2025 to USD 24.4/KG by Q4, a gain of 1.7%. Growing antihypertensive export and domestic cardiac demand drove modest firming through the year.
How We Can Help
Expert Market Research: Your Source for Real-Time Atenolol Price Intelligence
Expert Market Research tracks Atenolol prices continuously across every major producing and consuming region. The team traces causation through beta-blocker synthesis feedstock economics, antihypertensive and cardiac prescription cycles, and regional API production capacity. Contact Expert Market Research today for Atenolol pricing data, bespoke market analysis, and strategic procurement advisory.
Pricing Plans
Upto 15% Off
USD
-
$799 $699
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Key Questions Answered in the Report
Hypertension management as first-line or combination antihypertensive therapy takes the largest share globally, supported by competitive generic pricing and established tolerability across high- and middle-income health systems. Angina pectoris management, cardiac arrhythmia suppression, acute myocardial infarction early treatment, and off-label anxiety disorder and hyperthyroidism adjunctive use also consume significant volumes globally.
The Q2 2026 average was USD 27.3/KG in the United States, USD 19.0/KG in China, USD 33.5/KG in Germany, and USD 26.1/KG in India. Germany remains the highest-priced market.
The global average rose from USD 22.00/KG in Q1 to about USD 23.76/KG in Q2, a gain of around 8.0%. Spring antihypertensive and cardiac procurement and firmer synthesis feedstock costs drove the H1 surge.
Antihypertensive and cardiac management procurement cycles create alternating quarterly buying patterns. Post-treatment cycle moderation in Q1 and Q3 creates dips while spring and year-end procurement surges in Q2 and Q4 drive upticks.
The global average is expected in the USD 23.90 to 26.60/KG range for H2 2026, with continued firming as synthesis feedstock costs stay elevated and antihypertensive and cardiac treatment demand grows.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on antihypertensive and cardiac demand, and China prices lowest on domestic API capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to beta-blocker synthesis feedstock costs, antihypertensive prescribing volumes, and cardiac management guideline adoption. Synthesis precursor prices and hypertension treatment access expansion are key signals.
China and India hold the largest atenolol API synthesis capacity. Any synthesis feedstock cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time antihypertensive and cardiac formulation contracts around synthesis cost cycles, build cover when feedstock signals tighten, and monitor antihypertensive prescription volume data as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
- Report in Excel Format
- 3 Months Price Forecast
- Historical Prices for the Past 3 Years
-
Summary Of Factors Influencing Prices
- Current Price Overview
- 3-Month Price Forecast
- Historical Price Summary
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.